Skip to main content

Table 3 Alcohol consumption and the incidence of low eGFR in males and females

From: Association of alcohol consumption with the incidence of proteinuria and chronic kidney disease: a retrospective cohort study in Japan

 

Daily alcohol consumption categories (g of alcohol)

P- trend

No

 < 23 g

23–46

 ≥ 46

Males

 Incidence of CKD, n (%)

228 (3.1)

206 (3.3)

150 (3.5)

83 (4.7)

 

 IR per 1000PY

7.9

8.0

8.4

11.5

 

 Hazard ratio (95% CI)

  Unadjusted model

1.0 (reference)

0.99 (0.83–1.21)

0.97 (0.79–1.20)

1.32 (1.03–1.70) *

.172

  Adjusted model 1

1.0 (reference)

1.02 (0.84–1.23)

0.91 (0.73–1.12)

0.95 (0.73–1.24)

.432

  Adjusted model 2

1.0 (reference)

1.03 (0.85–1.24)

0.91 (0.73–1.12)

0.96 (0.73–1.25)

.454

  Adjusted model 3

1.0 (reference)

1.03 (0.85–1.24)

0.90 (0.73–1.11)

0.92 (0.71–1.20)

.342

Females

 Incidence of CKD, n (%)

120 (3.0)

69 (3.5)

38 (5.0)

28 (7.7)

 

 IR per 1000PY

8.3

10.0

13.0

20.1

 

 Hazard ratio (95% CI)

 Unadjusted model

1.0 (reference)

1.23 (0.91–1.65)

1.43 (0.99–2.06)

2.22 (1.47–3.36) *

 < .001

 Adjusted model 1

1.0 (reference)

1.23 (0.91–1.65)

1.21 (0.83–1.76) *

1.56 (1.01–2.39) *

.039

 Adjusted model 2

1.0 (reference)

1.22 (0.91–1.65)

1.19 (0.81–1.76)

1.65 (1.06–2.56) *

.030

 Adjusted model 3

1.0 (reference)

1.23 (0.91–1.65)

1.21 (0.83–1.79)

1.62 (1.04–2.53) *

.039

  1. PY person-years, CI confidence interval
  2. Multivariate model 1 adjusted for age (years) and eGFR (mL/min/1.73 m2) at baseline
  3. Model 2 adjusted for the covariates in model 1, body mass index (BMI) (kg/m2), and smoking status (never/former and current smokers)
  4. Model 3 adjusted for the covariates in model 2, and current treatment for comorbidities (hypertension, dyslipidemia, diabetes mellitus, and cardiovascular disease)
  5. *P < .05
  6. P-trend was derived from general linear models by treating alcohol consumption as a continuous linear term